-
Gilteritinib 40mg Tablets
What is Gilteritinib 40mg Tablets?
Gilteritinib 40mg Tablets is a prescription medicine used to treat adults with acute myeloid leukemia (AML) with an FMS-like tyrosine kinase 3 (FLT3) mutation when the disease has come back or has not improved after previous treatment(s). Your healthcare provider will perform a test to make sure Gilteritinib 40mg Tablets are right for you. It is not known if Gilteritinib 40mg Tablets is safe and effective in children.
What is the most important information I should know about Gilteritinib 40mg Tablets?
Differentiation Syndrome is one of the major negative effects that Gilteritinib 40mg Tablets may cause. Blood cell disorders such as Differentiation Syndrome can be fatal or life-threatening if left untreated. During the first three months of treatment, and even as soon as one day after commencing Gilteritinib 40mg Tablets, Differentiation Syndrome can occur. If you experience any of the following differentiation syndrome symptoms while taking Gilteritinib 40mg Tablets: fever, cough, dizziness or lightheadedness, rapid weight gain, difficulty breathing, swelling of your arms or legs, rash, decreased urination, call your healthcare provider or head straight to the nearest hospital emergency room. If you experience any of these differentiation syndrome symptoms, your doctor may prescribe a corticosteroid medication as well as monitor you in the hospital.
Who should not take Gilteritinib 40mg Tablets?
Do not take Gilteritinib 40mg Tablets if you are allergic to Gilteritinib or any of the ingredients in Gilteritinib 40mg Tablets.
What are the possible side effects of Gilteritinib 40mg Tablets?
Gilteritinib 40mg Tablets may cause serious side effects including:
See “What is the most important information I should know about Gilteritinib 40mg Tablets?” above.
Syndrome of Posterior Reversible Encephalopathy (PRES). If you use Gilteritinib 40mg Tablets, you can run the risk of getting PRES, a brain disorder. If you experience a seizure or rapidly worsening symptoms like headache, decreased alertness, disorientation, diminished vision, blurred vision, or other visual issues, notify your healthcare professional straight away. To screen for PRES, your healthcare professional will do a test. If you get PRES, your doctor will discontinue giving you Gilteritinib 40mg Tablets.
QTc prolongation is the term for alterations in your heart’s electrical activity. Life-threatening irregular heartbeats can result from QTc prolongation. Both before and throughout your Gilteritinib 40mg Tablet treatment, your healthcare practitioner will perform an electrocardiogram (ECG) to measure the electrical activity of your heart. If you experience fainting, dizziness, or lightheadedness, notify your healthcare professional right away. Low levels of potassium or magnesium in the blood increase the risk of QT prolongation. Blood tests will be performed by your healthcare practitioner to measure your magnesium and potassium levels both before and throughout Gilteritinib 40mg Tablet treatment.
pancreatitis, or inflammation of the pancreas. If you experience severe stomach pain that does not go away, you should notify your healthcare professional straight away. This pain may occur in the presence or absence of nausea and vomiting.
The most common side effects of Gilteritinib 40mg Tablets include:
Changes in liver function tests
Joint or muscle pain
Tiredness
Fever
Pain or sores in mouth or throat
Swelling of arms or legs
Rash
Diarrhea
Shortness of breath
Nausea
Cough
Constipation
Eye problems
Headache
Dizziness
Low blood pressure
Vomiting
Decreased urination
Your healthcare provider may tell you to decrease your dose, temporarily stop, or completely stop taking Gilteritinib 40mg Tablets if you develop certain side effects during treatment with Gilteritinib 40mg Tablets.
These are not all of the possible side effects of Gilteritinib 40mg Tablets. Call your doctor for medical advice about side effects.
What should I tell my doctor before taking Gilteritinib 40mg Tablets?
Tell your doctor:
About all of your medical conditions.
If you suffer from cardiac issues, such as long QT syndrome.
If you experience issues with abnormal levels of sodium, potassium, or magnesium in your body.
If you are or intend to get pregnant. Gilteritinib 40mg Tablets may be harmful to the developing fetus. If you become pregnant while taking Gilteritinib 40mg Tablets or suspect you might be pregnant, notify your doctor at away.
If you can become pregnant, your healthcare provider may perform a pregnancy test 7 days before you start treatment with Gilteritinib 40mg Tablets.
Females who can become pregnant should use effective birth control (contraception) during treatment with Gilteritinib 40mg Tablets and for 6 months after the last dose of Gilteritinib 40mg Tablets.
Males who have female partners who can become pregnant should use effective birth control (contraception) during treatment with Gilteritinib 40mg Tablets and for 4 months after the last dose of Gilteritinib 40mg Tablets.
If you are breastfeeding or plan to breastfeed. It is not known if Gilteritinib 40mg Tablets pass into your breast milk. Do not breastfeed during treatment with Gilteritinib 40mg Tablets and for 2 months after the last dose of Gilteritinib 40mg Tablets.
nearly every medication you take, including vitamins, herbal supplements, and both prescription and over-the-counter medications. The effects of other medications on Gilteritinib 40mg Tablets and the effects of other medications on Gilteritinib 40mg Tablets may coexist.
How should I take Gilteritinib 40mg Tablets?
Take Gilteritinib 40mg Tablets exactly as your healthcare provider tells you.
Do not change your dose or stop taking Gilteritinib 40mg Tablets unless your healthcare provider tells you to.
Take Gilteritinib 40mg Tablets 1 time a day at about the same time each day.
Swallow Gilteritinib 40mg Tablets tablets whole.
Gilteritinib 40mg Tablets can be taken with or without food.
Do not break, crush, or chew Gilteritinib 40mg Tablets tablets.
If you miss a dose of Gilteritinib 40mg Tablets, take your dose as soon as possible on the same day at least 12 hours before your next scheduled dose. Start your routine again the next day. Never take two doses in 12 hours.
-
Halaven 0.44 mg Injection
WHAT
IS HALAVEN INJECTION?Halaven is a medicine composition of Eribulin
that interferes with the growth and spread of cancer cells in the body.USES OF HALAVEN INJECTION:
Eribulin is used to treat
breast cancer that has spread to other parts of the body. Eribulin is also used
to treat liposarcoma, a rare type of cancer that develops in fatty tissue
anywhere in the body.Halaven is used to treat breast cancer that has
spread to other parts of the body.POSSIBLE
SIDE EFFECTS:Along with its needed
effects, eribulin (the active ingredient contained in Halaven) may cause some unwanted
effects. Although not all of these side effects may occur, if they do occur
they may need medical attention.COMMON SIDE EFFECTS MAY
INCLUDE:chest pain, severe dizziness, fast or
pounding heartbeats; numbness, tingling, or burning pain in your hands or feet;
pain or burning when you urinate; low potassium–confusion, uneven heart rate,
extreme thirst, increased urination, leg discomfort, muscle weakness or limp
feeling; or severe skin reaction–fever, sore throat, swelling in your face or
tongue, burning in your eyes, skin pain followed by a red or purple skin rash
that spreads and causes blistering and peeling.DRUGS PRECAUTIONS:
You should not use eribulin if you are allergic to it.
To make sure eribulin is safe for you, tell your doctor
if you have: liver disease; kidney disease; heart disease; peripheral vascular
disease such as Reynaud’s syndrome; or an electrolyte imbalance.Do not use eribulin if you are pregnant.
Do not breast-feed while you are using eribulin.
-
Harvoni Tablets Gilead Sciences, Inc.
Here are Harvoni (Ledipasvir/sofosbuvir) costs in :
– the US ($94,500)
– Canada ($80,000)
– India ($900)
– the UK (£39,000)
– Germany (48,000€)
– Egypt ($1200)
This medicine is a mix of ledipasvir and sofosbuvir and is utilized to treat incessant (durable) hepatitis C, a viral contamination of the liver. It might once in a while be utilized with another antiviral medicine (ribavirin). These medications work by lessening the measure of hepatitis C infection in your body, which enables your insusceptible framework to battle the contamination and may enable your liver to recuperate. Endless hepatitis C contamination can cause genuine liver issues, for example, scarring (cirrhosis), or liver tumor.
It is not known whether this treatment can keep you from passing the infection to others. Try not to share needles, and practice “more secure sex” (counting the utilization of latex condoms) to bring down the danger of passing the infection to others.
Step by step instructions to utilize Harvoni
Read the Patient Information Leaflet if accessible from your drug specialist before you begin taking ledipasvir/sofosbuvir and each time you get a refill. On the off chance that you have any inquiries, ask your specialist or drug specialist.
Take this pharmaceutical by mouth with or without nourishment as coordinated by your specialist, ordinarily once every day.
This pharmaceutical works best when the measure of medication in your body is kept at a steady level. In this way, take this medication at uniformly divided interims. To enable you to recollect, take it in the meantime every day.
Tell your specialist on the off chance that you upchuck inside 5 hours in the wake of taking this prescription. You may need to take another dosage.
Keep on taking ledipasvir/sofosbuvir for the full timeframe endorsed, regardless of the possibility that manifestations vanish a little while later. Ceasing the medicine too soon may bring about an arrival of the disease.
Acid neutralizers bring down the retention of ledipasvir. On the off chance that you are taking an acid neutralizer, take it no less than 4 hours earlier or 4 hours after this prescription.
Other corrosive bringing down meds for acid reflux, indigestion, or ulcers, (for example, medicine or over-the-counter meds including famotidine, omeprazole) may keep ledipasvir from working. Ask your specialist or drug specialist how to utilize these medicines securely.
Doses & Administration
Each tablet contains 90 mg ledipasvir and 400 mg sofosbuvir. Tablets include the following inactive ingredients: colloidal silicon dioxide, copovidone, croscarmellose sodium, lactose monohydrate, magnesium stearate, and microcrystalline cellulose. These tablets are film-coated with a coating material containing the following inactive ingredients: FD&C yellow #6/sunset yellow FCF aluminum lake, polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.
It is indicated with or without ribavirin for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1, 4, 5, or 6 infection.
Harvoni Side Effects:
If Harvoni is administered with ribavirin, refer to the prescribing information for ribavirin for a description of ribavirin-associated adverse reactions. The safety assessment was based on pooled data from three randomized, open-label Phase 3 clinical trials (ION-3, ION-1 and ION-2) of subjects with genotype 1 HCV with compensated liver disease (with and without cirrhosis) including 215, 539, and 326 subjects who received once daily by mouth for 8, 12 and 24 weeks, respectively.
The proportion of subjects who permanently discontinued treatment due to adverse events was 0%, less than 1%, and 1% for subjects receiving these tablets for 8, 12, and 24 weeks, respectively.
The most common adverse reactions (at least 10%) were fatigue and headache in subjects treated with 8, 12, or 24 weeks of Harvoni.
Potential For Drug Interaction
As Harvoni contains ledipasvir and sofosbuvir, any interactions that have been identified with these agents individually may occur with tablets.
After oral administration of tablets, sofosbuvir is rapidly absorbed and subject to extensive first-pass hepatic extraction. In clinical pharmacology studies, both sofosbuvir and the inactive metabolite GS-331007 were monitored for purposes of pharmacokinetic analyses. Ledipasvir is an inhibitor of the drug transporters P-gp and breast cancer resistance protein (BCRP) and may increase intestinal absorption of coadministered substrates for these transporters.
Ledipasvir and sofosbuvir are substrates of drug transporters P-gp and BCRP while GS-331007 is not. P-gp inducers (e.g., rifampin or St. John’s wort) may decrease ledipasvir and sofosbuvir plasma concentrations, leading to reduced therapeutic effect of Harvoni, and the use with P-gp inducers is not recommended with Harvoni.
-
HepBest 25mg Tablet
HepBest 25mg Tablet
HepBest 25mg tablet contains an active ingredient of Tenofovir Alafenamide (TAF) which works to stops the growth of virus in blood. Hepbest tablet is used in the treatment of HIV infection and chronic hepatitis B virus (HBV) infection.
Hepbest 25mg Uses
Hepbest 25mg Tablet is used in the treatment of HIV infection and chronic hepatitis B virus (HBV) infection.
Hepbest (TAF) Side Effects
Diarrhoea, Vomiting, Nausea, Dizziness, Rash, Feeling sick and more.
How to use Hepbest Medicine
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Hepbest 25mg Tablet is to be taken with food.
How Hepbest 25mg works
Hepbest medicine prevents the multiplication of HIV virus and chronic hepatitis B virus in human cells. Thus stops the hepatitis B and HIV virus from producing new viruses.
How to Order HepBest (Tenofovir Alafenamide) 25mg Tablets from India
If you wish to order HepBest Tenofovir Alafenamide (TAF) 25mg Tablets online from India at an affordable price, you just have to fill the “ASK Price” form. We will get in touch with you as soon as your order gets placed.
LetsMeds is a leading generic medicines exporter, supplier & distributor of HepBest Tenofovir Alafenamide (TAF) 25mg Tablets manufactured by Mylan Pharmaceuticals Pvt. Ltd. from India. We export HepBest Tenofovir Alafenamide (TAF) 25mg Tablets to China, Russia, Hong Kong, UK, USA, Vietnam, Russia, Singapore, Philippines, UAE, Saudi Arabia, Morocco, and other countries. To know more call us at +91-9205576166 or email at LetsMeds@gmail.com
-
HepBest 25mg Tablets : 替諾福韋阿拉芬酰胺 (TAF)
TAF，替诺福韦二代。 新药彻底治愈乙肝不可能，但能实现临床治愈。 TAF能实现临床治愈，是目前乙肝治疗界公认的最高水平。 什么是临床治愈?又为什么治愈不可能?摊开来讲好比将军带兵攻打敌国，大败敌军生擒国王，将其下监，严加看管，此后四海之内再无敌军，这就是临床治愈。但这国王装疯卖傻以求活命，并仍有一定的可能在守卫疏忽之时越狱，东山再起，这就是无法完全治愈。 TAF作为替诺福韦第二代，几乎没有肾毒性，取代替诺福韦TDF是早晚的问题。
具体表现在：
1.更好的骨骼安全性 2.更好的肾脏安全性 3.耐药性最低 4.十分之一剂量，可达到国内一线治疗药物TDF的同等药效 我适合服用TAF吗?
TAF并非适合每一个乙肝患者，
它更加适合以下患者：
1.首次服用抗病毒药物的乙肝患者 2.在服用其他抗病毒药物的患者，更换药物时需询问医生 3.服用其他药物时，在3年内产生耐药性的，强烈推荐 4.为预防乙肝妈妈将病毒传给宝宝，哺乳期妇女建议使用 5.还患有糖尿病或肾损伤、骨质疏松严重的患者.
WhatsApp / Viber
Available On All Major Platform
+91 7428091874
Express Worldwide Shipping
Order Above $99
